Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipoic Acid and Omega-3 Fatty Acids in Alzheimer's Disease
NCT01058941Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Sep 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alpha-lipoic acid and fish oil concentrate in Alzheimer's disease (AD), sponsored by Oregon Health & Science University. Started Sep 2010; status: completed.
02
Drugs
alpha-lipoic acidfish oil concentrate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01058941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01058941.